Hereditary spherocytosis or HS is a genetic disorder characterized by anemia, jaundice and splenomegaly. The genetic defects lie in the red cell membrane proteins causing cells to lose their surface area and become spherical in shape. They are also less flexible than normal red blood cells. When these cells pass through the spleen, they become trapped in narrow blood passages which leads to cell destruction and hemolysis (break up). Enlargement of the spleen or splenomegaly then occurs due to the build up of red blood cells.
The breakdown of RBCs leads to increase bilirubin levels in the blood causing jaundice and gallstone formation in many patients. A small percentage of HS patients may present with jaundice at birth, and require blood transfusion. About 20% to 30% of HS patients may not show signs nor symptoms of the disease, as the destruction of red blood cells can be offset by the production of new red blood cells in the bone marrow.
In most cases, however, moderate to severe hemolytic anemia becomes apparent when the compensatory mechanism is not enough.